Severe hypofibrinogenemia associated with imatinib and prednisone therapy in Philadelphia chromosome–positive acute lymphoblastic leukemia
- 31 January 2018
- journal article
- letter
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 59 (10) , 2516-2517
Abstract
(2018). Severe hypofibrinogenemia associated with imatinib and prednisone therapy in Philadelphia chromosome–positive acute lymphoblastic leukemia. Leukemia & Lymphoma. Ahead of Print.Keywords
This publication has 11 references indexed in Scilit:
- Final Results of Northern Italy Leukemia Group (NILG) Trial 10/07 Combining Pediatric-Type Therapy with Minimal Residual Disease Study and Risk-Oriented Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia (ALL)Blood, 2016
- Dasatinib as first-line treatment for adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemiaBlood, 2011
- Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome–positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocolBlood, 2007
- Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 studyLeukemia, 2006
- Acute lymphoblastic leukemia in the elderlyThe Hematology Journal, 2002
- Hypofibrinogenemia induced by prednisolone therapy in a patient with chronic lymphocytic leukemia complicated with autoimmune hemolytic anemiaAmerican Journal of Hematology, 1997
- Hypofibrinogenemia in a girl with Langerhans cell histiocytosis during etoposide and prednisolone therapyPediatrics International, 1993
- Changes in hemostatic and fibrinolytic proteins in patients receiving L-asparaginase therapyAmerican Journal of Hematology, 1989
- Effect of L-asparaginase administration on coagulation and platelet function in children with leukemia.Journal of Clinical Oncology, 1987
- Deficiency of fibrinogen and factor VII following treatment of severe aplastic anaemia with anti‐thymocyte globulin and high‐dose methylprednisoloneScandinavian Journal of Haematology, 1985